Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2022 call → NOWe need to determine if management explains the company's business direction by narrating what counterparties are doing and scaling, with the company already embedded in that growth, and the counterparties' trajectory early and large relative to the company. Key elements: management speaks about counterparties' business as part of its own, company already inside that growth, and trajectory early and large. In the transcript, management discusses various segments. For Intermodal, they talk about rail providers' service challenges, but they don't narrate rail providers' own expansion plans. They mention BNSF capacity becoming available next year, but that's about their own capacity. For Dedicated, they talk about strong demand and growth, but that's about their own fleet growth, not about specific customers' own trajectories. They mention private fleet conversions, but not specific counterparties' scaling. For Final Mile, they mention demand and new opportunities, but not specific counterparties' build-outs. The question asks: does management explain where the company's business is going by narrating what its counterparties are themselves doing and scaling? The answer seems NO. Management focuses on their own actions, market conditions, and broad demand. They don't describe specific customers' or partners' own expansion plans as the driver of their own growth. They mention rail providers' service issues but not their scaling. They mention customer demand but not specific counterparties' trajectories. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.